Characterization of disulfide linkages in recombinant human granulocyte-colony stimulating factor

Rapid Communications in Mass Spectrometry

Volumn 27, Issue 9, 2013, Pages 940-946

  Mo, Jingjie ^a   Tymiak, Adrienne A ^a   Chen, Guodong ^a  

^a BRISTOL MYERS SQUIBB RESEARCH AND DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACIDS; DISSOCIATION; ESCHERICHIA COLI; MASS SPECTROMETRY; SULFUR COMPOUNDS;

CYSTEINE RESIDUES; DIFFERENT MASS; DISULFIDE LINKAGES; GLYCOSYLATED; GRANULOCYTE-COLONY STIMULATING FACTOR; MAPPING ANALYSIS; MODEL PROTEINS; PEPTIDE MAPPING; RECOMBINANT HUMAN GRANULOCYTE COLONY STIMULATING FACTORS; THERAPEUTIC PROTEIN;

PEPTIDES;

EID: 84876276212     PISSN: 09514198     EISSN: 10970231     Source Type: Journal    
DOI: 10.1002/rcm.6530     Document Type: Article

References (34)

1. W.J. Wedemeyer, E. Welker, M. Narayan, H.A. Scheraga,. Disulfide bonds and protein folding. Biochemistry 2000, 39, 7032.
2. J. Wypych, M. Li, A. Guo, Z. Zhang, T. Martinez, M.J. Allen, S. Fodor, D.N. Kelner, G.C. Flynn, Y. D. Liu, P.V. Bondarenko, M.S. Ricci, T.M. Dillon, A. Balland,. Human IgG2 antibodies display disulfide-mediated structural isoforms. J. Biol. Chem. 2008, 283, 16194.
3. T.M. Dillon, M.S. Ricci, C. Vezina, G.C. Flynn, Y.D. Liu, D.S. Rehder, M. Plant, B. Henkle, Y. Li, S. Deechongkit, B. Varnum, J. Wypych, A. Balland, P.V. Bondarenko,. Structural and functional characterization of disulfide isoforms of the human IgG2 subclass. J. Biol. Chem. 2008, 283, 16206.
4. N.A. Nicola,. Murine granulocyte colony-stimulating factor: actions on normal and leukemic cells. Behring Inst. Mitt. 1988, 207.
5. D. Metcalf,. The granulocyte-macrophage colony-stimulating factors. Science 1985, 229, 16.
6. T.L. Holyoake,. Cytokines at the research-clinical interface: potential applications. Blood Rev. 1996, 10, 189.
7. J. Nemunaitis,. A comparative review of colony-stimulating factors. Drugs 1997, 54, 709.
8. J.L. Gabrilove,. Clinical applications of granulocyte colony stimulating factor (G-CSF). Growth Factors 1992, 6, 187.
9. L.M. Hollingshead, K.L. Goa,. Recombinant granulocyte colony-stimulating factor (rG-CSF). A review of its pharmacological properties and prospective role in neutropenic conditions. Drugs 1991, 42, 300.
10. S. Akbarzadeh, J.E. Layton,. Granulocyte colony-stimulating factor receptor: structure and function. Vitam. Horm. 2001, 63, 159.
11. K. Welte, J. Gabrilove, M.H. Bronchud, E. Platzer, G. Morstyn,. Filgrastim (r-metHuG-CSF): the first 10 years. Blood 1996, 88, 1907.
12. M.H. Bronchud, J.H. Scarffe, N. Thatcher, D. Crowther, L.M. Souza, N.K. Alton, N.G. Testa, T. M. Dexter,. Phase I/II study of recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for small cell lung cancer. Br. J. Cancer 1987, 56, 809.
13. S. Nagata, M. Tsuchiya, S. Asano, et al,. Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 1986, 319, 415.
14. L.M. Souza, T.C. Boone, J. Gabrilove, et al,. Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells. Science 1986, 232, 61.
15. H.S. Lu, T.C. Boone, L.M. Souza, P.H. Lai,. Disulfide and secondary structures of recombinant human granulocyte colony stimulating factor. Arch. Biochem. Biophys 1989, 268, 81.
16. M. Oh-eda, M. Hasegawa, K. Hattori, H. Kuboniwa, T. Kojima, T. Orita, K. Tomonou, T. Yamazaki, N. Ochi,. O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. J. Biol. Chem. 1990, 265, 11432.
17. A.L. Vanz, G. Renard, M.S. Palma, J.M. Chies, S.L. Dalmora, L.A. Basso, D.S. Santos,. Human granulocyte colony stimulating factor (hG-CSF): cloning, overexpression, purification and characterization. Microb. Cell Fact. 2008, 7, 13.
18. K.E. Ahmed, W.Q. Chen, J. P. John, S.U. Kang, G. Lubec,. Complete sequencing of the recombinant granulocyte-colony stimulating factor (filgrastim) and detection of biotinylation by mass spectrometry. Amino Acids 2010, 38, 1043.
19. H. Wei, J. Ahn, Y.Q. Yu, A. Tymiak, J.R. Engen, G. Chen,. Using hydrogen/deuterium exchange mass spectrometry to study conformational changes in granulocyte colony stimulating factor upon PEGylation. J. Am. Soc. Mass Spectrom. 2012, 23, 498.
20. J.A. Ji, B. Zhang, W. Cheng, Y.J. Wang,. Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization. J. Pharm. Sci 2009, 98, 4485.
21. T. Arakawa, S.J. Prestrelski, L.O. Narhi, T.C. Boone, W.C. Kenney,. Cysteine 17 of recombinant human granulocyte-colony stimulating factor is partially solvent-exposed. J. Protein Chem. 1993, 12, 525.
22. F.M. Veronese, A. Mero, F. Caboi, M. Sergi, C. Marongiu, G. Pasut,. Site-specific pegylation of G-CSF by reversible denaturation. Bioconjug. Chem. 2007, 18, 1824.
23. S.W. Raso, J. Abel, J.M. Barnes, K.M. Maloney, G. Pipes, M.J. Treuheit, J. King, D.N. Brems,. Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state. Protein Sci. 2005, 14, 2246.
24. R.S. Rajan, T. Li, M. Aras, C. Sloey, W. Sutherland, H. Arai, R. Briddell, O. Kinstler, A.M. Lueras, Y. Zhang, H. Yeghnazar, M. Treuheit, D. N. Brems,. Modulation of protein aggregation by polyethylene glycol conjugation: GCSF as a case study. Protein Sci. 2006, 15, 1063.
25. H.S. Lu, C.L. Clogston, L.O. Narhi, L.A. Merewether, W.R. Pearl, T.C. Boone,. Folding and oxidation of recombinant human granulocyte colony stimulating factor produced in Escherichia coli. Characterization of the disulfide-reduced intermediates and cysteine-serine analogs. J. Biol. Chem. 1992, 267, 8770.
26. J. Mo, A. A. Tymiak, G. Chen,. Structural mass spectrometry in biologics discovery: advances and future trends. Drug Discov. Today 2012, 17, 1323.
27. H. Liu, G. Gaza-Bulseco, C. Chumsae, A. Newby-Kew,. Characterization of lower molecular weight artifact bands of recombinant monoclonal IgG1 antibodies on non-reducing SDS-PAGE. Biotechnol. Lett. 2007, 29, 1611.
28. S.L. Wu, H. Jiang, W.S. Hancock, B.L. Karger,. Identification of the unpaired cysteine status and complete mapping of the 17 disulfides of recombinant tissue plasminogen activator using LC-MS with electron transfer dissociation/collision induced dissociation. Anal Chem. 2010, 82, 5296.
29. Y. Wang, Q. Lu, S.L. Wu, B L. Karger, W.S. Hancock,. Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation. Anal Chem. 2011, 83, 3133.
30. D.G. Smyth, O.O. Blumenfeld, W. Konigsberg,. Reactions of N-ethylmaleimide with peptides and amino acids. Biochem. J. 1964, 91, 589.
31. M.L. Gross, G. Chen, B.N. Pramanik,. Protein and Peptide Mass Spectrometry in Drug Discovery. Wiley, Hoboken, NJ, 2012.
32. W. Ni, M. Lin, P. Salinas, P. Savickas, S.L. Wu, B.L. Karger,. Complete mapping of a cystine knot and nested disulfides of recombinant human arylsulfatase a by multi-enzyme digestion and LC-MS analysis using CID and ETD. J. Am. Soc. Mass Spectrom. 2013, 24, 125.
33. Y. Shen, R. Zhao, S. J. Berger, G. A. Anderson, N. Rodriguez, R. D. Smith,. High-efficiency nanoscale liquid chromatography coupled on-line with mass spectrometry using nanoelectrospray ionization for proteomics. Anal. Chem. 2002, 74, 4235.
34. C.E. Doneanu, A. Xenopoulos, K. Fadgen, J. Murphy, S.J. Skilton, H. Prentice, M. Stapels, W. Chen,. Analysis of host-cell proteins in biotherapeutic proteins by comprehensive online two-dimensional liquid chromatography/mass spectrometry. MAbs 2012, 4, 24.